Literature DB >> 22070219

Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets.

Elizabeth Scarr1.   

Abstract

Phylogenetically, acetylcholine is an ancient neurochemical. Therefore, it is not surprising that cholinergic neurons project extensively throughout the central nervous system, innervating a wide range of structures within the brain. In fact, acetylcholine is involved in processes that underpin some of our most basic central functions. Both muscarinic and nicotinic receptor families, which mediate cholinergic transmission, have been implicated in the pathophysiology of psychiatric and neurological disorders. The question that remains to be definitively answered is whether or not these receptors are viable targets for the development of future therapeutic agents.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22070219      PMCID: PMC6493542          DOI: 10.1111/j.1755-5949.2011.00249.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  21 in total

1.  Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats.

Authors:  Maricarmen Hernández-Rodríguez; Ivonne Maciel Arciniega-Martínez; Iohanan Daniel García-Marín; José Correa-Basurto; Martha Cecilia Rosales-Hernández
Journal:  Mol Neurobiol       Date:  2020-07-07       Impact factor: 5.590

2.  Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.

Authors:  Marissa A Smail; Jessica L Soles; Tracy E Karwoski; Robert T Rubin; Michael E Rhodes
Journal:  Brain Res Bull       Date:  2017-11-07       Impact factor: 4.077

3.  Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Ryoichi Toyoshima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-09       Impact factor: 3.000

4.  The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

Authors:  Herbert Renz-Polster; Marie-Eve Tremblay; Dorothee Bienzle; Joachim E Fischer
Journal:  Front Cell Neurosci       Date:  2022-05-09       Impact factor: 6.147

5.  Genetic and neurophysiological correlates of the age of onset of alcohol use disorders in adolescents and young adults.

Authors:  David B Chorlian; Madhavi Rangaswamy; Niklas Manz; Jen-Chyong Wang; Danielle Dick; Laura Almasy; Lance Bauer; Kathleen Bucholz; Tatiana Foroud; Victor Hesselbrock; Sun J Kang; John Kramer; Sam Kuperman; John Nurnberger; John Rice; Marc Schuckit; Jay Tischfield; Howard J Edenberg; Alison Goate; Laura Bierut; Bernice Porjesz
Journal:  Behav Genet       Date:  2013-08-21       Impact factor: 2.805

6.  Cholinergic connectivity: it's implications for psychiatric disorders.

Authors:  Elizabeth Scarr; Andrew S Gibbons; Jaclyn Neo; Madhara Udawela; Brian Dean
Journal:  Front Cell Neurosci       Date:  2013-05-03       Impact factor: 5.505

7.  Lacidipine Prevents Scopolamine-Induced Memory Impairment by Reducing Brain Oxido-nitrosative Stress in Mice.

Authors:  Kunal Khurana; Manish Kumar; Nitin Bansal
Journal:  Neurotox Res       Date:  2021-03-15       Impact factor: 3.911

Review 8.  Muscarinic Acetylcholine Receptors in the Retina-Therapeutic Implications.

Authors:  Yue Ruan; Andreas Patzak; Norbert Pfeiffer; Adrian Gericke
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

9.  Control of Brain State Transitions with a Photoswitchable Muscarinic Agonist.

Authors:  Almudena Barbero-Castillo; Fabio Riefolo; Carlo Matera; Sara Caldas-Martínez; Pedro Mateos-Aparicio; Julia F Weinert; Aida Garrido-Charles; Enrique Claro; Maria V Sanchez-Vives; Pau Gorostiza
Journal:  Adv Sci (Weinh)       Date:  2021-05-21       Impact factor: 16.806

Review 10.  Emerging opportunities for serotypes of botulinum neurotoxins.

Authors:  Zhongxing Peng Chen; J Glenn Morris; Ramon L Rodriguez; Aparna Wagle Shukla; John Tapia-Núñez; Michael S Okun
Journal:  Toxins (Basel)       Date:  2012-11-07       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.